deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02666742

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation (STROKE-VT)

SafeTy and Efficacy of Direct Oral Anticoagulant Versus Aspirin for Reduction Of RisK of CErebrovascular Events in Patients Undergoing Ventricular Tachycardia Ablation (STROKE-VT)

Sponsor: Kansas City Heart Rhythm Institute

Conditions Premature Ventricular Contraction Stroke Ventricular Tachycardia
Interventions Aspirin DOAC
Updated 15 times since 2017 Last updated: Aug 18, 2022 Started: Feb 16, 2017 Primary completion: May 1, 2020 Completion: Apr 30, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Premature Ventricular Contraction and Stroke and is currently completed. Kansas City Heart Rhythm Institute leads this study, which shows 15 recorded versions since 2017 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~May 2018 · 13 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshot~Jun 2019 – ~Jan 2021 · 19 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 9 months · monthly snapshot

Change History

15 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

▶ Show 10 earlier versions

  1. Sep 2022 — Dec 2022 [monthly]

    Completed PHASE4

  2. Dec 2021 — Sep 2022 [monthly]

    Completed PHASE4

  3. Oct 2021 — Dec 2021 [monthly]

    Completed PHASE4

    Status: Terminated → Completed

  4. Jan 2021 — Oct 2021 [monthly]

    Terminated PHASE4

  5. Jun 2019 — Jan 2021 [monthly]

    Terminated PHASE4

  6. Jun 2018 — Jun 2019 [monthly]

    Terminated PHASE4

    Status: Recruiting → Terminated

  7. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE4

  8. Apr 2017 — May 2018 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  9. Feb 2017 — Apr 2017 [monthly]

    Not Yet Recruiting PHASE4

  10. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kansas City Heart Rhythm Institute
  • Kansas City Heart Rhythm Research Foundation
Data source: Kansas City Heart Rhythm Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations